Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up

Tue, 23rd Oct 2012 09:23

Aggreko: UBS cuts target from 2,750p to 2,550p, buy rating kept.ARM Holdings: Investec keeps buy rating and 800p target.Avacta: Panmure Gordon keeps buy rating and 1.75p target.AZ Electronic: Canaccord Genuity ups target from 360p to 376p, buy rating kept.Babcock: JPMorgan Cazenove ups target from 990p to 1,050p, overweight rating kept.Barclays: Exane BNP Paribas ups target from 330p to 340p, outperform rating kept; HSBC lifts target from 180p to 260p, neutral rating kept.BBA Aviation: Westhouse Securities downgrades to neutral.BP: Jefferies keeps hold rating and 450p target.BP Marsh & Partners: Panmure Gordon ups target from 125p to 130p, buy rating kept.British American Tobacco: Credit Suisse ups target from 3,400p to 3,430p, outperform rating kept.Bullabulling Gold: Westhouse Securities initiates with buy rating and 21p target..Burberry: Deutsche Bank keeps hold rating and 1,275p target.CRH: HSBC downgrades to neutral, target cut from 16p to 15p.Direct Line: Nomura initiates with reduce rating and 174p target.e-Therapeutics: Panmure Gordon keeps buy rating and 73p target.Experian: Jefferies keeps buy rating and 1,060p target; Seymour Pierce keeps reduce rating and 1,000p target.Genel Energy: HSBC downgrades to neutral, target upped from 816p to 830p.Hammerson: Jefferies raises target from 501p to 503p, hold rating kept.Inchcape: Panmure Gordon keeps hold rating and 430p target.Johnson Matthey: UBS cuts target from 2,378p to 2,300p, neutral rating kept.Laird: Investec keeps hold rating and 225p target.Mulberry: Barclays Capital cuts target from 1,600p to 1,250p, equal weight rating kept; Panmure Gordon slashes target from 2,000p to 1,100p, buy rating kept.N Brown: UBS ups target from 285p to 340p, buy rating kept.Premier Foods: Panmure Gordon keeps hold rating and 90p target; Investec puts buy rating and 100p target under review.Redrow: UBS downgrades to neutral, target lifted from 160p to 170p.SDL: Goldman Sachs cuts target from 915p to 820p, buy rating kept.Unilever: Oriel Securities downgrades to hold, target raised from 2,200p to 2,320p.Whitbread: Investec maintains sell rating and 1,650p target; Nomura maintains buy rating and 2,650p target; Panmure Gordon keeps hold rating and 1,994p target; Investec keeps sell rating and 1,650p target.BC
More News
2 Jul 2021 13:47

E-therapeutics meets 'key milestone' in Galapagos collaboration

(Sharecast News) - E-therapeutics has met a key milestone in its collaboration with Galapagos, a commercial-stage company specialising in the discovery and development of small-molecule medicines with novel modes of action, with a focus on inflammation, fibrosis and kidney disease, it announced on Friday.

Read more
9 Jun 2021 16:08

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
2 Jun 2021 16:02

EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus

EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus

Read more
2 Jun 2021 09:42

E-therapeutics brings in Alison Gallafent as head of IP

(Sharecast News) - Drug discovery company e-therapeutics announced the appointment of Alison Gallafent as its head of intellectual property on Wednesday.

Read more
14 May 2021 14:20

E-therapeutics raises £22.5m to expand capabilities and pipeline

(Sharecast News) - E-therapeutics has completed a placing, subscription and retail offer via PrimaryBid, it announced on Friday, conditionally raising gross proceeds of £22.5m to help expand its drug discovery and development capabilities and asset pipeline.

Read more
14 May 2021 10:23

AIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins

AIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins

Read more
14 May 2021 09:48

e-Therapeutics raises GBP23 million to expand capability and pipeline

e-Therapeutics raises GBP23 million to expand capability and pipeline

Read more
13 May 2021 17:52

IN BRIEF: e-Therapeutics to raise GBP20 million to expand capability

IN BRIEF: e-Therapeutics to raise GBP20 million to expand capability

Read more
13 May 2021 16:40

TRADING UPDATES: Profit rises for Griffin Mining, Jersey Electricity

TRADING UPDATES: Profit rises for Griffin Mining, Jersey Electricity

Read more
13 May 2021 10:29

AIM WINNERS & LOSERS: PHSC plans share buyback as earnings rise

AIM WINNERS & LOSERS: PHSC plans share buyback as earnings rise

Read more
6 May 2021 15:51

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
23 Apr 2021 11:31

AIM WINNERS & LOSERS: Bigblu Broadband rises on Quickline stake sale

AIM WINNERS & LOSERS: Bigblu Broadband rises on Quickline stake sale

Read more
23 Apr 2021 11:29

e-Therapeutics gets two payments from Galapagos under collaboration

e-Therapeutics gets two payments from Galapagos under collaboration

Read more
23 Apr 2021 10:18

E-therapeutics to receive two milestone payments from Galapagos

(Sharecast News) - E-therapeutics has met two key milestones in its collaboration with small-molecule medicines specialist Galapagos, it announced on Friday.

Read more
29 Mar 2021 15:13

EXECUTIVE CHANGES: F&C Investment Trust hires CBI chief economist

EXECUTIVE CHANGES: F&C Investment Trust hires CBI chief economist

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.